← Back
Data updated: Jun 28, 2026
CRISTAL ASU LLC
Pharma Pharmaceuticals
CRISTAL ASU LLC is a pharmaceutical company with 2 FDA-approved products.
2018
Since
2
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
2 Small Molecules
CRISTAL ASU LLC's Key Drugs
CRISTAL ASU LLC's core commercial portfolio centers on OXYGEN, USP, NITROGEN, NF — its most strategically important drugs approved in the last 15 years.
CRISTAL ASU LLC's Recent FDA Approvals
New NDA/BLA approvals for CRISTAL ASU LLC over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CRISTAL ASU LLC's Therapeutic Areas
Disease areas where CRISTAL ASU LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CRISTAL ASU LLC Pipeline Snapshot
Active clinical trials for CRISTAL ASU LLC across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • OXYGEN, USP leads revenue
- • 2 key drugs tracked
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (2)
Discontinued (0)
Company Info
- First Approval
- 2018-04-09
- Latest
- 2018-09-10
- Applications
- 2